India bans exports of injection Remdesivir and Remdesivir API
India bans exports of injection Remdesivir and Remdesivir API and all domestic manufactures of Remdesivir to display on their website, details of their stockists/ distributors to facilitate access to the drug.
India is witnessing a recent surge in COVID cases. As on 11.04.2021, there are 11.08 lakh active COVID cases and they are steadily increasing. This has led to a sudden spike in demand for Injection Remdesivir used in treatment of COVID patients. There is a potential of further increase in this demand in the coming days.